Exelixis | EXEL - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q3 Sep/2025 0.88 0.78 Nov/03
FY2026Q2 Jun/2026 0.91 0.85 0.75 Aug/05
FY2026Q1 Mar/2026 0.87 0.76 0.62 May/05
FY2025Q4 Dec/2025 0.97 0.76 0.55 Feb/10
FY2025Q3 Sep/2025 0.78 0.68 0.47 Nov/04




Eps Cambiamento Data
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
Akebia Therapeutics USD -0.04 0.04 2025-12
Amgen USD 6.29 1.14 2026-06
AstraZeneca USD 2.63 0.05 2026-06
Bayer EUR 0.95 1.76 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Cytokinetics USD -1.5 0.17 2026-06
Eisai JPY 64.71 76.24 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Exelixis USD 0.91 0.04 2026-06
Genmab DKK 5.43 4.6 2026-06
Glaxosmithkline GBP 0.62 0.41 2026-03
Incyte USD 3.09 1.28 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
MacroGenics USD -0.58 0.36 2026-03
Merck USD -0.13 1.15 2026-06
Moderna USD -1.97 1.43 2026-06
Nektar Therapeutics USD -1.78 0.43 2026-03
Neurocrine Biosciences USD 2.85 0.91 2026-06
Novartis USD 2.41 0.42 2026-06
Pfizer USD 0.77 0.02 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Sanofi EUR 2.17 2.84 2026-03
Takeda JPY 71.65 87.21 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
Xencor USD -0.29 1.42 2026-06